DOJ Backs Off Antitrust Enforcement For Covid Collaboration

By on April 15, 2020

April 15, 2020

At the companies’ request, the Department of Justice Antitrust Division has issued a business review letter, saying it does not intend to challenge a proposed collaboration among five medical/surgical and pharmaceutical distributors. The companies say they are working along with government agencies to facilitate distribution of critical supplies to U.S. healthcare providers. This letter, says a post from law firm McDermott Will & Emery, “underscores the flexibility of the US antitrust regulators towards competitor collaborations aimed at increasing the supply and distribution of medical equipment.” The post takes a close look at the letter and comes up with a number of takeaways regarding DOJ’s reasoning in this case, and what it suggests regarding how enforcers are likely to consider future competitor collaboration in this field.


Read the full article at:

McDermott Will & Emery

Leave a Reply

Your email address will not be published. Required fields are marked *

Do NOT follow this link or you will be banned from the site!